AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Jan 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-01-02

Reporting Person: Quimi Daphne (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-02	Common Stock	F	7113	$9.55	Disposed	187274	Direct
2020-01-03	Common Stock	F	5305	$9.18	Disposed	181969	Direct